Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-01-09

Clinical Trial Update: Evaluate LAE102 in Healthy and Overweight/Obese Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating LAE102 in healthy and overweight/obese individuals is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LAE102

Snippet

Sponsor: Laekna Limited | Conditions: Overweight and Obese Volunteers | Phase 1 | Status: RECRUITING